Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	SETD1B KMT2D KMT2A	1.10e-05	8	118	3	GO:0140945
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	SETD1B KMT2D KMT2A	2.34e-05	10	118	3	GO:0140999
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	SETD1B KMT2D KMT2A	2.13e-04	20	118	3	GO:0042800
GeneOntologyMolecularFunction	acid-amino acid ligase activity	TTLL8 TTLL11 TTL	3.27e-04	23	118	3	GO:0016881
GeneOntologyMolecularFunction	neuroligin family protein binding	NRXN3 NRXN2	3.42e-04	5	118	2	GO:0097109
GeneOntologyMolecularFunction	thioredoxin-dependent peroxiredoxin activity	PRDX4 PRDX2	7.13e-04	7	118	2	GO:0140824
GeneOntologyMolecularFunction	thioredoxin peroxidase activity	PRDX4 PRDX2	7.13e-04	7	118	2	GO:0008379
GeneOntologyCellularComponent	microtubule	MAP1A MDM1 AKNA TOGARAM1 TTLL8 DNAH14 EHHADH TTLL11 TTL NINL MAP3K11 KIFC1	5.33e-05	533	119	12	GO:0005874
GeneOntologyCellularComponent	supramolecular polymer	WHRN SCO2 FLNB COL8A1 COL11A2 MAP1A MDM1 AKNA TOGARAM1 TTLL8 DNAH14 EHHADH TTLL11 TTL NINL MAP3K11 KIFC1 NPNT	1.31e-04	1187	119	18	GO:0099081
GeneOntologyCellularComponent	supramolecular fiber	WHRN SCO2 FLNB COL11A2 MAP1A MDM1 AKNA TOGARAM1 TTLL8 DNAH14 EHHADH TTLL11 TTL NINL MAP3K11 KIFC1 NPNT	3.68e-04	1179	119	17	GO:0099512
Domain	Post-SET_dom	SETD1B KMT2D KMT2A	1.17e-04	16	114	3	IPR003616
Domain	PostSET	SETD1B KMT2D KMT2A	1.17e-04	16	114	3	SM00508
Domain	POST_SET	SETD1B KMT2D KMT2A	1.17e-04	16	114	3	PS50868
Domain	FYrich_C	KMT2D KMT2A	3.65e-04	5	114	2	IPR003889
Domain	FYrich_N	KMT2D KMT2A	3.65e-04	5	114	2	IPR003888
Domain	1-cysPrx_C	PRDX4 PRDX2	3.65e-04	5	114	2	PF10417
Domain	FYRC	KMT2D KMT2A	3.65e-04	5	114	2	SM00542
Domain	FYRN	KMT2D KMT2A	3.65e-04	5	114	2	SM00541
Domain	SLED	SFMBT1 SFMBT2	3.65e-04	5	114	2	IPR021987
Domain	SLED	SFMBT1 SFMBT2	3.65e-04	5	114	2	PF12140
Domain	Peroxiredoxin_C	PRDX4 PRDX2	3.65e-04	5	114	2	IPR019479
Domain	FYRN	KMT2D KMT2A	3.65e-04	5	114	2	PF05964
Domain	FYRC	KMT2D KMT2A	3.65e-04	5	114	2	PF05965
Domain	FYRC	KMT2D KMT2A	3.65e-04	5	114	2	PS51543
Domain	FYRN	KMT2D KMT2A	3.65e-04	5	114	2	PS51542
Domain	LRR_8	PODNL1 PIDD1 CHADL TPBGL LRRC47 GP5	6.36e-04	171	114	6	PF13855
Domain	Syndecan	NRXN3 NRXN2	7.60e-04	7	114	2	PF01034
Domain	AhpC/TSA	PRDX4 PRDX2	7.60e-04	7	114	2	IPR000866
Domain	AhpC-TSA	PRDX4 PRDX2	7.60e-04	7	114	2	PF00578
Domain	Syndecan/Neurexin_dom	NRXN3 NRXN2	7.60e-04	7	114	2	IPR027789
Domain	LRR_TYP	PODNL1 PIDD1 CHADL TPBGL LRRC47 GP5	7.62e-04	177	114	6	SM00369
Domain	Leu-rich_rpt_typical-subtyp	PODNL1 PIDD1 CHADL TPBGL LRRC47 GP5	7.62e-04	177	114	6	IPR003591
Domain	MBT	SFMBT1 SFMBT2	1.29e-03	9	114	2	SM00561
Domain	MBT	SFMBT1 SFMBT2	1.29e-03	9	114	2	PS51079
Domain	Leu-rich_rpt	PODNL1 PIDD1 CHADL TPBGL LRRC47 NOD2 GP5	1.38e-03	271	114	7	IPR001611
Domain	LRR	PODNL1 PIDD1 CHADL LRRC47 NOD2 GP5	1.47e-03	201	114	6	PS51450
Domain	ANF_lig-bd_rcpt	GRIN2C GRM6 GUCY2D	1.48e-03	37	114	3	IPR001828
Domain	ANF_receptor	GRIN2C GRM6 GUCY2D	1.48e-03	37	114	3	PF01094
Domain	MBT	SFMBT1 SFMBT2	1.61e-03	10	114	2	PF02820
Domain	Mbt	SFMBT1 SFMBT2	1.61e-03	10	114	2	IPR004092
Domain	Peripla_BP_I	GRIN2C GRM6 GUCY2D	1.72e-03	39	114	3	IPR028082
Domain	Laminin_G_2	COL11A2 NRXN3 NRXN2	1.86e-03	40	114	3	PF02210
Domain	SET	SETD1B KMT2D KMT2A	1.99e-03	41	114	3	PF00856
Domain	Thioredoxin_domain	SCO2 PRDX4 PRDX2	1.99e-03	41	114	3	IPR013766
Domain	ConA-like_dom	COL11A2 BSPRY NRXN3 NRXN2 LRBA NPNT	2.26e-03	219	114	6	IPR013320
Domain	THIOREDOXIN_2	SCO2 PRDX4 PRDX2	2.29e-03	43	114	3	PS51352
Domain	LamG	COL11A2 NRXN3 NRXN2	2.44e-03	44	114	3	SM00282
Domain	-	COL11A2 NRXN3 NRXN2 LRBA	2.74e-03	95	114	4	2.60.120.200
Domain	TTL	TTLL11 TTL	2.76e-03	13	114	2	PS51221
Domain	TTL/TTLL_fam	TTLL11 TTL	2.76e-03	13	114	2	IPR004344
Domain	TTL	TTLL11 TTL	2.76e-03	13	114	2	PF03133
Domain	SET	SETD1B KMT2D KMT2A	2.78e-03	46	114	3	SM00317
Domain	-	CNNM4 KCNH2 ADI1	3.14e-03	48	114	3	2.60.120.10
Domain	Neurexin-like	NRXN3 NRXN2	3.20e-03	14	114	2	IPR003585
Domain	4.1m	NRXN3 NRXN2	3.20e-03	14	114	2	SM00294
Domain	ASX_HYDROXYL	HEG1 NRXN3 SCUBE2 NPNT	3.29e-03	100	114	4	PS00010
Domain	SET_dom	SETD1B KMT2D KMT2A	3.52e-03	50	114	3	IPR001214
Domain	SET	SETD1B KMT2D KMT2A	3.52e-03	50	114	3	PS50280
Domain	-	PODNL1 PIDD1 CHADL TPBGL LRRC47 NOD2 GP5	3.56e-03	321	114	7	3.80.10.10
Domain	RmlC-like_jellyroll	CNNM4 KCNH2 ADI1	3.73e-03	51	114	3	IPR014710
Domain	L_dom-like	PODNL1 PIDD1 CHADL TPBGL LRRC47 NOD2 GP5	4.01e-03	328	114	7	IPR032675
Domain	EGF-type_Asp/Asn_hydroxyl_site	HEG1 NRXN3 SCUBE2 NPNT	4.06e-03	106	114	4	IPR000152
Domain	Laminin_G	COL11A2 NRXN3 NRXN2	5.35e-03	58	114	3	IPR001791
Domain	P-loop_NTPase	TRIT1 PEX6 MAGI3 GAL3ST4 DNAH14 SWSAP1 NOD2 MYO15B MDN1 HELZ2 GNAS KIFC1	5.62e-03	848	114	12	IPR027417
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SPHK2 ABL1 SETD1B SZT2 MEX3D FBRSL1 AKNA PEX6 MIB2 FAAP100 NOD2 HEG1 KMT2D MDN1 KCNH2 HELZ2 NINL MAP3K11 TNFAIP2 LRBA TIMM22 SMAD7	4.15e-11	1105	122	22	35748872
Pubmed	Neurexins play a crucial role in cerebellar granule cell survival by organizing autocrine machinery for neurotrophins.	GRIN2C NRXN3 NRXN2	1.68e-07	4	122	3	35385735
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	SCO2 FLNB COL8A1 PIDD1 MAGI3 PTGER1 DNAH14 LRRC47 MYO15B NOXO1 MDN1 CHRD GP5	2.04e-06	736	122	13	29676528
Pubmed	Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.	SETD1B KMT2D KMT2A	2.33e-06	8	122	3	23130995
Pubmed	The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.	SETD1B KMT2D KMT2A	2.33e-06	8	122	3	22266653
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PGS1 FBRSL1 PEX6 MIB2 MAP3K6 ZXDB AP5B1 DDHD1 KMT2A TNFAIP2 DBR1 KIFC1	3.29e-06	650	122	12	38777146
Pubmed	Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.	SETD1B KMT2D KMT2A	3.48e-06	9	122	3	22665483
Pubmed	Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression.	KMT2D KMT2A KIFC1	6.81e-06	11	122	3	18082152
Pubmed	Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.	SETD1B KMT2D KMT2A	9.05e-06	12	122	3	27563068
Pubmed	Inhibition of sphingosine kinase 2 attenuates hypertrophic scar formation via upregulation of Smad7 in human hypertrophic scar fibroblasts.	SPHK2 SMAD7	1.22e-05	2	122	2	32705254
Pubmed	Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo.	KMT2D KMT2A	1.22e-05	2	122	2	26711341
Pubmed	Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant.	KMT2D KMT2A	1.22e-05	2	122	2	24423662
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	PGS1 PRRX1 SZT2 KMT2D MYO15B TTLL11 HELZ2 EPS8L3 GNAS DBR1	2.63e-05	552	122	10	10737800
Pubmed	Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior.	NRXN3 NRXN2	3.65e-05	3	122	2	34133920
Pubmed	Conditional Knockout of Neurexins Alters the Contribution of Calcium Channel Subtypes to Presynaptic Ca2+ Influx.	NRXN3 NRXN2	3.65e-05	3	122	2	38891114
Pubmed	Sphingosine Kinase-2 Deficiency Ameliorates Kidney Fibrosis by Up-Regulating Smad7 in a Mouse Model of Unilateral Ureteral Obstruction.	SPHK2 SMAD7	3.65e-05	3	122	2	28807595
Pubmed	The within-subject application of diffusion tensor MRI and CLARITY reveals brain structural changes in Nrxn2 deletion mice.	NRXN3 NRXN2	3.65e-05	3	122	2	30858964
Pubmed	Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.	KMT2D KMT2A	3.65e-05	3	122	2	26902498
Pubmed	Neurexins 1-3 Each Have a Distinct Pattern of Expression in the Early Developing Human Cerebral Cortex.	NRXN3 NRXN2	3.65e-05	3	122	2	28013231
Pubmed	alpha-Neurexins are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction.	NRXN3 NRXN2	3.65e-05	3	122	2	16406382
Pubmed	Ketamine Restores Thalamic-Prefrontal Cortex Functional Connectivity in a Mouse Model of Neurodevelopmental Disorder-Associated 2p16.3 Deletion.	NRXN3 NRXN2	3.65e-05	3	122	2	31812984
Pubmed	Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.	KMT2D KMT2A	3.65e-05	3	122	2	23932714
Pubmed	MLL histone methylases regulate expression of HDLR-SR-B1 in presence of estrogen and control plasma cholesterol in vivo.	KMT2D KMT2A	3.65e-05	3	122	2	23192982
Pubmed	Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing.	NRXN3 NRXN2	3.65e-05	3	122	2	12036300
Pubmed	β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling.	NRXN3 NRXN2	3.65e-05	3	122	2	26213384
Pubmed	Neurexin gene family variants as risk factors for autism spectrum disorder.	NRXN3 NRXN2	3.65e-05	3	122	2	29045040
Pubmed	Alternative Splicing of Presynaptic Neurexins Differentially Controls Postsynaptic NMDA and AMPA Receptor Responses.	NRXN3 NRXN2	3.65e-05	3	122	2	31005376
Pubmed	Structural and functional characterization of the IgSF21-neurexin2α complex and its related signaling pathways in the regulation of inhibitory synapse organization.	NRXN3 NRXN2	3.65e-05	3	122	2	38571813
Pubmed	Deletion of β-Neurexins in Mice Alters the Distribution of Dense-Core Vesicles in Presynapses of Hippocampal and Cerebellar Neurons.	NRXN3 NRXN2	3.65e-05	3	122	2	35173587
Pubmed	Activation of the Intracellular Pattern Recognition Receptor NOD2 Promotes Acute Myeloid Leukemia (AML) Cell Apoptosis and Provides a Survival Advantage in an Animal Model of AML.	NOD2 KMT2A	3.65e-05	3	122	2	32094205
Pubmed	Neurexins are differentially expressed in the embryonic nervous system of mice.	NRXN3 NRXN2	3.65e-05	3	122	2	7722633
Pubmed	Cdc2/cyclin B1 regulates centrosomal Nlp proteolysis and subcellular localization.	CCNB1 NINL	3.65e-05	3	122	2	20890132
Pubmed	Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals.	NRXN3 NRXN2	3.65e-05	3	122	2	26446217
Pubmed	Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity.	NRXN3 NRXN2	3.65e-05	3	122	2	11944992
Pubmed	Alternative splicing of neurexins 1-3 is modulated by neuroinflammation in the prefrontal cortex of a murine model of multiple sclerosis.	NRXN3 NRXN2	3.65e-05	3	122	2	33058888
Pubmed	Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules.	NRXN3 NRXN2	3.65e-05	3	122	2	17035546
Pubmed	Neurexins: three genes and 1001 products.	NRXN3 NRXN2	3.65e-05	3	122	2	9448462
Pubmed	Deletion of α-neurexin II results in autism-related behaviors in mice.	NRXN3 NRXN2	3.65e-05	3	122	2	25423136
Pubmed	Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia.	KMT2D KMT2A	3.65e-05	3	122	2	30315824
Pubmed	Importance of the renal ion channel TRPM6 in the circadian secretion of renin to raise blood pressure.	TRPM6 CNNM4	3.65e-05	3	122	2	34140503
Pubmed	Structural basis for activity regulation of MLL family methyltransferases.	SETD1B KMT2D KMT2A	6.18e-05	22	122	3	26886794
Pubmed	Transcription factor Ap2delta associates with Ash2l and ALR, a trithorax family histone methyltransferase, to activate Hoxc8 transcription.	TFAP2D KMT2D	7.29e-05	4	122	2	18495928
Pubmed	Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins.	NRXN3 NRXN2	7.29e-05	4	122	2	14983056
Pubmed	Whirlin complexes with p55 at the stereocilia tip during hair cell development.	WHRN GNAS	7.29e-05	4	122	2	16829577
Pubmed	Carm1 regulates Pax7 transcriptional activity through MLL1/2 recruitment during asymmetric satellite stem cell divisions.	KMT2D KMT2A	7.29e-05	4	122	2	22863532
Pubmed	Deorphanizing FAM19A proteins as pan-neurexin ligands with an unusual biosynthetic binding mechanism.	NRXN3 NRXN2	7.29e-05	4	122	2	32706374
Pubmed	KDM5A noncanonically binds antagonists MLL1/2 to mediate gene regulation and promotes epithelial to mesenchymal transition.	KMT2D KMT2A	7.29e-05	4	122	2	37722486
Pubmed	A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity.	KMT2D KMT2A	7.29e-05	4	122	2	23129768
Pubmed	Nonredundant antioxidant defense by multiple two-cysteine peroxiredoxins in human prostate cancer cells.	PRDX4 PRDX2	7.29e-05	4	122	2	12080185
Pubmed	TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade.	GRM6 GNAS	7.29e-05	4	122	2	19966281
Pubmed	Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996.	ABL1 KMT2A	7.29e-05	4	122	2	34048072
Pubmed	CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins.	NRXN3 NRXN2	7.29e-05	4	122	2	8786425
Pubmed	The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers.	KMT2D KMT2A	7.29e-05	4	122	2	24081332
Pubmed	Deletion of alpha-neurexins does not cause a major impairment of axonal pathfinding or synapse formation.	NRXN3 NRXN2	7.29e-05	4	122	2	17347997
Pubmed	Neurexins cluster Ca2+ channels within the presynaptic active zone.	NRXN3 NRXN2	7.29e-05	4	122	2	32134527
Pubmed	Critical Roles of the Histone Methyltransferase MLL4/KMT2D in Murine Hepatic Steatosis Directed by ABL1 and PPARγ2.	ABL1 KMT2D	7.29e-05	4	122	2	27806304
Pubmed	Neurexins regulate presynaptic GABAB-receptors at central synapses.	NRXN3 NRXN2	7.29e-05	4	122	2	33888718
Pubmed	MDM1 is a microtubule-binding protein that negatively regulates centriole duplication.	MDM1 CEP164	1.21e-04	5	122	2	26337392
Pubmed	Evolving Catalytic Properties of the MLL Family SET Domain.	KMT2D KMT2A	1.21e-04	5	122	2	26320581
Pubmed	Conditional Deletion of All Neurexins Defines Diversity of Essential Synaptic Organizer Functions for Neurexins.	NRXN3 NRXN2	1.21e-04	5	122	2	28472659
Pubmed	Concerted roles of LRRTM1 and SynCAM 1 in organizing prefrontal cortex synapses and cognitive functions.	NRXN3 NRXN2	1.21e-04	5	122	2	36709330
Pubmed	Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation.	SETD1B KMT2A	1.21e-04	5	122	2	25561738
Pubmed	Trans-synaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum.	NRXN3 NRXN2	1.21e-04	5	122	2	20537373
Pubmed	MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.	KMT2D KMT2A	1.21e-04	5	122	2	28609655
Pubmed	Neuroligins and neurexins link synaptic function to cognitive disease.	NRXN3 NRXN2	1.21e-04	5	122	2	18923512
Pubmed	Acetylcholinesterase-transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin Ibeta gene expression followed by late-onset neuromotor deterioration.	NRXN3 NRXN2	1.21e-04	5	122	2	9223334
Pubmed	Nuclear-encoded mitochondrial ribosomal proteins are required to initiate gastrulation.	MARS2 TRIT1 TIMM22	1.29e-04	28	122	3	32376682
Pubmed	Smad7 Inhibits chondrocyte differentiation at multiple steps during endochondral bone formation and down-regulates p38 MAPK pathways.	COL11A2 SMAD7	1.81e-04	6	122	2	18644788
Pubmed	FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair.	FAAP100 FANCE	1.81e-04	6	122	2	18285517
Pubmed	The incidence of T-cell receptor gene rearrangements in childhood B-lineage acute lymphoblastic leukemia is related to immunophenotype and fusion oncogene expression.	ABL1 KMT2A	1.81e-04	6	122	2	16386788
Pubmed	Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis.	NRXN3 NRXN2	1.81e-04	6	122	2	12827191
Pubmed	Cleavage of TFIIA by Taspase1 activates TRF2-specified mammalian male germ cell programs.	KMT2D KMT2A	1.81e-04	6	122	2	24176642
Pubmed	GRWD1-WDR5-MLL2 Epigenetic Complex Mediates H3K4me3 Mark and Is Essential for Kaposi's Sarcoma-Associated Herpesvirus-Induced Cellular Transformation.	KMT2D KMT2A	1.81e-04	6	122	2	34933446
Pubmed	Structures, alternative splicing, and neurexin binding of multiple neuroligins.	NRXN3 NRXN2	1.81e-04	6	122	2	8576240
Pubmed	Presynaptic α2δ-2 Calcium Channel Subunits Regulate Postsynaptic GABAA Receptor Abundance and Axonal Wiring.	NRXN3 NRXN2	1.81e-04	6	122	2	30683685
Pubmed	MLL associates specifically with a subset of transcriptionally active target genes.	KMT2D KMT2A	1.81e-04	6	122	2	16199523
Pubmed	Detection of mutations in LRPAP1, CTSH, LEPREL1, ZNF644, SLC39A5, and SCO2 in 298 families with early-onset high myopia by exome sequencing.	SCO2 SLC39A5	1.81e-04	6	122	2	25525168
Pubmed	HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages.	FLNB CCNB1 KIFC1	1.94e-04	32	122	3	27114546
Pubmed	Mieap forms membrane-less organelles involved in cardiolipin metabolism.	PGS1 CRLS1	2.53e-04	7	122	2	38322995
Pubmed	Clustered PHD domains in KMT2/MLL proteins are attracted by H3K4me3 and H3 acetylation-rich active promoters and enhancers.	KMT2D KMT2A	2.53e-04	7	122	2	36598580
Pubmed	Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes.	KMT2D KMT2A	2.53e-04	7	122	2	19219072
Pubmed	Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.	ABL1 FANCE NRXN2 SHARPIN	2.80e-04	89	122	4	18950845
Pubmed	SH2/SH3 adaptor proteins can link tyrosine kinases to a Ste20-related protein kinase, HPK1.	ABL1 MAP3K11	3.37e-04	8	122	2	9346925
Pubmed	Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways.	NRXN3 NRXN2	3.37e-04	8	122	2	30871858
Pubmed	Cyclin M2 (CNNM2) knockout mice show mild hypomagnesaemia and developmental defects.	TRPM6 CNNM4	3.37e-04	8	122	2	33859252
Pubmed	The mutational landscape of lethal castration-resistant prostate cancer.	KMT2D KMT2A	3.37e-04	8	122	2	22722839
Pubmed	Combinatorial expression of neurexins and LAR-type phosphotyrosine phosphatase receptors instructs assembly of a cerebellar circuit.	NRXN3 NRXN2	3.37e-04	8	122	2	37591863
Pubmed	FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway.	FAAP100 FANCE	4.32e-04	9	122	2	17396147
Pubmed	Molecular self-avoidance in synaptic neurexin complexes.	NRXN3 NRXN2	4.32e-04	9	122	2	34919427
Pubmed	SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance.	PRDX4 TNFAIP2	4.32e-04	9	122	2	20157331
Pubmed	The SUMO-specific isopeptidase SENP3 regulates MLL1/MLL2 methyltransferase complexes and controls osteogenic differentiation.	KMT2D KMT2A	4.32e-04	9	122	2	24930734
Pubmed	PRDX6 Inhibits Neurogenesis through Downregulation of WDFY1-Mediated TLR4 Signal.	PRDX4 PRDX2	4.32e-04	9	122	2	30097850
Pubmed	WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development.	KMT2D KMT2A	4.32e-04	9	122	2	15960974
Pubmed	Transsynaptic Binding of Orphan Receptor GPR179 to Dystroglycan-Pikachurin Complex Is Essential for the Synaptic Organization of Photoreceptors.	GRM6 GPC5	4.32e-04	9	122	2	30282023
Pubmed	Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling.	NOD2 SHARPIN	4.32e-04	9	122	2	23818254
Pubmed	Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression.	KMT2D KMT2A	4.32e-04	9	122	2	16951254
Pubmed	PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor.	NRXN3 NRXN2	4.32e-04	9	122	2	9707552
Pubmed	Identification of novel Smad binding proteins.	PEX6 SMAD7	4.32e-04	9	122	2	14651998
Pubmed	Physical Interactions and Functional Coordination between the Core Subunits of Set1/Mll Complexes and the Reprogramming Factors.	KMT2D KMT2A	4.32e-04	9	122	2	26691508
Pubmed	Comparative proteomic analysis identifies protein disulfide isomerase and peroxiredoxin 1 as new players involved in embryonic interdigital cell death.	PRDX4 PRDX2	4.32e-04	9	122	2	15858817
Interaction	TOP3B interactions	SCO2 SPHK2 ABL1 SETD1B SZT2 MEX3D FBRSL1 AKNA PEX6 MIB2 FAAP100 NOD2 HEG1 KMT2D MDN1 KCNH2 HELZ2 NINL MAP3K11 TNFAIP2 GNAS LRBA TIMM22 SMAD7	3.20e-06	1470	117	24	int:TOP3B
Cytoband	9q32	WHRN BSPRY AKNA	2.73e-04	47	122	3	9q32
Cytoband	Ensembl 112 genes in cytogenetic band chr9q32	WHRN BSPRY AKNA	3.28e-04	50	122	3	chr9q32
GeneFamily	Tubulin tyrosine ligase family	TTLL8 TTLL11 TTL	1.72e-05	14	67	3	779
GeneFamily	Peroxiredoxins	PRDX4 PRDX2	2.01e-04	6	67	2	953
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETD1B KMT2D KMT2A	2.68e-04	34	67	3	487
GeneFamily	Sterile alpha motif domain containing\|MBT domain containing	SFMBT1 SFMBT2	4.79e-04	9	67	2	1263
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	MAP3K6 MAP3K11	3.54e-03	24	67	2	654
GeneFamily	PHD finger proteins	KMT2D PHF3 KMT2A	4.54e-03	90	67	3	88
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL8A1 MAGI3 TACC2 DNAH14 RTKN2 GPC5 LRBA NPNT	6.81e-08	195	122	8	9406866f99555198a9be311fbd65751b70f35446
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	FLNB COL8A1 MAGI3 TACC2 RTKN2 HEG1 GPC5	4.52e-07	170	122	7	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	COL8A1 MAGI3 TACC2 DNAH14 RTKN2 GPC5 NPNT	7.41e-07	183	122	7	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	FLNB COL8A1 MAGI3 RTKN2 HEG1 FAM167A NPNT	7.41e-07	183	122	7	6821dca076318115d360ff426eb1218cfe104063
ToppCell	Control-Epithelial-ATI\|World / Disease state, Lineage and Cell class	COL8A1 MAGI3 TACC2 RTKN2 FAM167A GPC5 NPNT	7.98e-07	185	122	7	0563d5042bb96ecce8446fbf26d05ef7a45e23c5
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	RCCD1 ZXDB FANCE SCUBE2 HELZ2 NINL LRBA	8.27e-07	186	122	7	77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	RCCD1 ZXDB FANCE SCUBE2 HELZ2 NINL LRBA	8.27e-07	186	122	7	13bc41c60fd628af31899a5e8b480e06cc4781be
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|368C / Donor, Lineage, Cell class and subclass (all cells)	RCCD1 MAGI3 ZXDB FANCE SCUBE2 NINL LRBA	8.57e-07	187	122	7	b827d9da7032bf051756ddf88352af922eb0f87b
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	RCCD1 MAGI3 ZXDB FANCE SCUBE2 NINL LRBA	8.57e-07	187	122	7	61c00604dda8b36a5c3eea6554e5601aa1b884f7
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	COL8A1 MAGI3 TACC2 DNAH14 RTKN2 GPC5 NPNT	8.88e-07	188	122	7	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL8A1 MAGI3 TACC2 DNAH14 RTKN2 GPC5 NPNT	1.10e-06	194	122	7	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	AT1-AT2_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	PODNL1 HIF3A RTKN2 HEG1 NRXN3 FAM167A	3.00e-06	145	122	6	cd5de30fd948024e3ad043c9411ce9f2722178b2
ToppCell	368C-Fibroblasts-Fibroblast-H-\|368C / Donor, Lineage, Cell class and subclass (all cells)	COL8A1 TRIT1 PRRX1 CCNB1 NRXN2 CHRD	3.94e-06	152	122	6	dbfb4d4de36ef9f5c7da1950baa915b12788685e
ToppCell	368C-Fibroblasts-Fibroblast-H\|368C / Donor, Lineage, Cell class and subclass (all cells)	COL8A1 TRIT1 PRRX1 CCNB1 NRXN2 CHRD	3.94e-06	152	122	6	9f3682da00fd627e80aa820ecc6f5fed23b9738a
ToppCell	Control\|World / group, cell type (main and fine annotations)	MAGI3 TACC2 RTKN2 NRXN3 GPC5 NPNT	7.00e-06	168	122	6	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL8A1 PRRX1 COL11A2 CHADL SFMBT2 KIAA1755	7.25e-06	169	122	6	58e22f9119240664515fe91ca53812611a8f17d6
ToppCell	AT1-AT2_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	FLNB COL8A1 MAGI3 RTKN2 FAM167A NPNT	8.84e-06	175	122	6	bdd85ba280648a0283c1984662a34c7b840f64dd
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PODNL1 COL8A1 COL11A2 CHADL SORCS3 TNFAIP2	8.84e-06	175	122	6	085cceb1fc2c4ae2f27e85cea5702defecc2cf44
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	COL8A1 MAGI3 TACC2 RTKN2 GPC5 NPNT	1.01e-05	179	122	6	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SFMBT1 FLNB PRRX1 HEG1 NINL KIAA1755	1.01e-05	179	122	6	ce3ca7f3a5864e62307aa744a3173f350a90df28
ToppCell	COPD-Epithelial-ATI\|World / Disease state, Lineage and Cell class	COL8A1 TACC2 RTKN2 FAM167A GPC5 NPNT	1.11e-05	182	122	6	e95d946a43b1579af199900bb0e3eacbb9d65300
ToppCell	COVID-19-lung-AT1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL8A1 MAGI3 TACC2 RTKN2 GPC5 NPNT	1.14e-05	183	122	6	7b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCell	COVID-19-Epithelial_cells-ECM-high_epithelial\|COVID-19 / group, cell type (main and fine annotations)	FLNB COL8A1 MAGI3 TACC2 HMGCS1 GPC5	1.14e-05	183	122	6	dc1d380bf7564f290256cb7108063d1bd2da732b
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	COL8A1 MAGI3 TACC2 RTKN2 GPC5 NPNT	1.18e-05	184	122	6	561592edc3083fad41b91811151b442207c65dd9
ToppCell	Control-Epithelial-ATI\|Control / Disease state, Lineage and Cell class	COL8A1 TACC2 RTKN2 FAM167A GPC5 NPNT	1.29e-05	187	122	6	fdd1c57b61ca9392ac27661a82729f37593df63c
ToppCell	AT1-AT2_cells-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	COL8A1 MAGI3 RTKN2 HEG1 FAM167A NPNT	1.33e-05	188	122	6	be710bc957118cf426dd71c2d57e6f1b41c9a467
ToppCell	COPD-Epithelial-ATI\|Epithelial / Disease state, Lineage and Cell class	COL8A1 RTKN2 HEG1 FAM167A GPC5 NPNT	1.37e-05	189	122	6	14e8e57e4db336fbef005270647983b4edf407c0
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	COL8A1 MAGI3 TACC2 DNAH14 GPC5 NPNT	1.50e-05	192	122	6	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	COL8A1 MAGI3 TACC2 DNAH14 GPC5 NPNT	1.50e-05	192	122	6	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar-AT1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL8A1 MAGI3 RTKN2 FAM167A GPC5 NPNT	1.78e-05	198	122	6	54228dd9a50616d2022712d162a419ed0327cabd
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL8A1 MAGI3 TACC2 DNAH14 GPC5 NPNT	1.83e-05	199	122	6	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL8A1 MAGI3 TACC2 DNAH14 GPC5 NPNT	1.83e-05	199	122	6	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL8A1 MAGI3 TACC2 RTKN2 FAM167A NPNT	1.83e-05	199	122	6	aca81a879ef9c196bd1885eff4c63ffe6c9682b7
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT1\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	COL8A1 MAGI3 TACC2 RTKN2 FAM167A NPNT	1.89e-05	200	122	6	3d51aebf626dd4656ab4aac8a20d761b8062c42d
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm\|5w / Sample Type, Dataset, Time_group, and Cell type.	AKNA NOXO1 HELZ2 CHRD KIAA1755 DBR1	1.89e-05	200	122	6	0927061536a664b4f7feb9e5b0a8c11ca0d5955c
ToppCell	COVID-19-COVID-19_Mild\|COVID-19 / Disease, condition lineage and cell class	AKNA DDHD1 HELZ2 TNFAIP2 GNAS SMAD7	1.89e-05	200	122	6	62c25042086f1afd1102e0720e933c2e476468fd
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_4\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	TPBGL SFMBT2 HELZ2 TUG1 CCDC17	3.41e-05	134	122	5	9e12aac8f42790c2f104dfd61c87aa99fc7925f1
ToppCell	AT1-AT2_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	COL8A1 MAGI3 PM20D2 RTKN2 NPNT	4.20e-05	140	122	5	45d52a086ced8d58e01ac51ac4a90338e8649b16
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 TACC2 LACTBL1 SORCS3 GPC5	4.50e-05	142	122	5	5b6b0c611c83b23ef7289854a515b78f6cf84500
ToppCell	facs-Thymus-Flowthrough-24m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WHRN MAP3K6 LACTBL1 KMT2A GPC5	7.46e-05	158	122	5	c870fd17213129943562487338e2669e2930d719
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GPR27 ZAR1 TNFAIP2 GNAS HCRT	7.46e-05	158	122	5	35f3082109a5930b89d14db3c8fa93148d3a5dd4
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI3 TACC2 DNAH14 GPC5 NPNT	7.69e-05	159	122	5	e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI3 TACC2 HIF3A GPC5 NPNT	8.40e-05	162	122	5	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDHR2 EHHADH GUCY2D SLC39A5 NPNT	9.69e-05	167	122	5	ed7e785dcd25777f64e0c2596ada4f5a5ea17121
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AKNA EHHADH TTL DBR1 KIFC1	1.02e-04	169	122	5	7cb1b87be66a22fe5731bb1b55bc515920fe3e8b
ToppCell	droplet-Kidney-nan-18m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDHR2 EHHADH GUCY2D SLC39A5 NPNT	1.02e-04	169	122	5	f00741203efa0b948db7223ee8c19bdd0918258a
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NECAB2 MAGI3 TACC2 TPBGL SORCS3	1.05e-04	170	122	5	14aa86a4f526ed6986afcb28c49225522055550c
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NECAB2 MAGI3 TPBGL NRXN3 SORCS3	1.08e-04	171	122	5	5efd15300f865ebf651e0888265cbd717bc3b9d3
ToppCell	wk_20-22-Mesenchymal-Chondrocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	COL8A1 PRRX1 COL11A2 DNAH14 CYP2U1	1.08e-04	171	122	5	d2938639e9a7c349e5a6ec61724222f9d127c89f
ToppCell	AT1_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	COL8A1 RTKN2 HEG1 GPC5	1.10e-04	90	122	4	6cbf30dd3992d8ccfaa74ad9781b9f8735f1ef69
ToppCell	367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	MEX3D MAGI3 NOXO1 MDS2 GPC5	1.11e-04	172	122	5	a9e65201ad9ab4f64251aba2c0bb3d8f9e0193b6
ToppCell	367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|367C / Donor, Lineage, Cell class and subclass (all cells)	MEX3D MAGI3 NOXO1 MDS2 GPC5	1.11e-04	172	122	5	26006967d0c82f7bd9b36a18e97a1b93e856aa67
ToppCell	AT1_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	COL8A1 TACC2 RTKN2 HEG1 FAM167A	1.14e-04	173	122	5	3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e
ToppCell	Mesenchymal_cells-Osteo-CAR\|Mesenchymal_cells / Lineage and Cell class	PODNL1 COL8A1 MIPEP CYP2U1 NPNT	1.17e-04	174	122	5	430e3cd61bc2a471959faa40e817aa4dd7d82d28
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	COL8A1 MAGI3 RTKN2 GPC5 NPNT	1.17e-04	174	122	5	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRRX1 TPBGL ZXDB KCNH2	1.20e-04	92	122	4	84ac97a16920b912a67ea80e71146eddf9dfa92f
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFMBT1 FBRSL1 DAO GRIN2C SFMBT2	1.21e-04	175	122	5	91cb819a1786020713b7e64480de0545380daae9
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NECAB2 MAGI3 TACC2 TPBGL SORCS3	1.24e-04	176	122	5	05ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI3 NRXN3 PHF3 LRBA NPNT	1.27e-04	177	122	5	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRRX1 MAP1A GAL3ST4 NRXN2 AP5B1	1.34e-04	179	122	5	b44e2d53b82c3c141bfc6539054b19708200a0d9
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI3 HIF3A NRXN3 GPC5 LRBA	1.34e-04	179	122	5	815b959ce8721c5ded70c0ca6e318dafc691746e
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI3 TACC2 RTKN2 NRXN3 NPNT	1.34e-04	179	122	5	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL8A1 PRRX1 ZIC4 CHRD KIAA1755	1.38e-04	180	122	5	39ae8586efd91536e9ac6408d26de7e6d6237c41
ToppCell	facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCDHGC4 PEX6 SCUBE2 CYP2U1 NPNT	1.38e-04	180	122	5	d33bb00f2b7d07dda9015cb8eafd742c2b2e9ace
ToppCell	IPF-Epithelial-ATI\|World / Disease state, Lineage and Cell class	COL8A1 TACC2 RTKN2 GPC5 NPNT	1.49e-04	183	122	5	31fef35ecf30162662f24d335d8f0cceacc07039
ToppCell	droplet-Large_Intestine\|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDHR2 BSPRY CNNM4 NOXO1 EPS8L3	1.49e-04	183	122	5	9d7ffcb9804b9a52448ccb56c9370b317a4b52a5
ToppCell	wk_20-22-Mesenchymal-Chondrocyte-intermediate_chondrocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	COL8A1 PRRX1 COL11A2 DNAH14 CYP2U1	1.49e-04	183	122	5	1464b5c4425e8776c4aeb4d2b560481d4bf13931
ToppCell	IPF-Epithelial-ATI\|IPF / Disease state, Lineage and Cell class	COL8A1 TACC2 RTKN2 GPC5 NPNT	1.49e-04	183	122	5	c0a3541c45bd0c587603521f392f42dd86c3c35b
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	MAGI3 TACC2 HMGCS1 GPC5 NPNT	1.53e-04	184	122	5	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL8A1 MAGI3 RTKN2 GPC5 NPNT	1.53e-04	184	122	5	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI3 TACC2 RTKN2 GPC5 NPNT	1.53e-04	184	122	5	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL8A1 MAGI3 RTKN2 GPC5 NPNT	1.53e-04	184	122	5	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL7C CHADL HEG1 FAM167A SMAD7	1.60e-04	186	122	5	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI3 TACC2 RTKN2 NRXN3 NPNT	1.60e-04	186	122	5	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	COL8A1 MAGI3 RTKN2 GPC5 NPNT	1.60e-04	186	122	5	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	COPD-Epithelial-ATI\|COPD / Disease state, Lineage and Cell class	COL8A1 TACC2 RTKN2 GPC5 NPNT	1.60e-04	186	122	5	df0977f6f48a2d4e11b59971f098b01204242f0f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HIF3A GRIN2C ZIC4 KIAA1755 GPC5	1.64e-04	187	122	5	4d2115a05ec36dd179ca1d4a525f2d4501aea557
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI3 TACC2 HIF3A GPC5 NPNT	1.64e-04	187	122	5	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLNB COL8A1 MAGI3 RTKN2 GPC5	1.64e-04	187	122	5	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	COL8A1 MAGI3 RTKN2 GPC5 NPNT	1.64e-04	187	122	5	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	Control-Epithelial-ATI\|Epithelial / Disease state, Lineage and Cell class	COL8A1 RTKN2 HEG1 FAM167A GPC5	1.64e-04	187	122	5	3a032432f780525f4f4c2a358897d9989b1ecae7
ToppCell	ASK454-Epithelial-Type_1\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	COL8A1 CNNM4 RTKN2 FAM167A NPNT	1.69e-04	188	122	5	13f8ce8f24ac7d7ed87f4ae3b8f4096de29383c2
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	COL8A1 MAGI3 RTKN2 GPC5 NPNT	1.73e-04	189	122	5	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HIF3A GRIN2C ZIC4 MYO15B KIAA1755	1.77e-04	190	122	5	2de8e4cfeee350a9a76af749d6ce58d948c129b8
ToppCell	facs-Large_Intestine\|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDHR2 BSPRY CNNM4 NOXO1 EPS8L3	1.77e-04	190	122	5	cf752ab09db7432a24ecdc60336ade738a9b703b
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL8A1 MAGI3 RTKN2 HEG1 GPC5	1.77e-04	190	122	5	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	LAM-Epithelial-AT1\|LAM / Condition, Lineage and Cell class	COL8A1 MAGI3 RTKN2 FAM167A NPNT	1.81e-04	191	122	5	66875b2ec2c510489407f3e433a90cdf74a15094
ToppCell	facs-Heart-LV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL8A1 PRRX1 CHRD KIAA1755 TNFAIP2	1.81e-04	191	122	5	b7a57691a4742070cee640e285c1f4d0da95baf1
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	MAGI3 TACC2 DNAH14 GPC5 NPNT	1.81e-04	191	122	5	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI3 TACC2 DNAH14 GPC5 NPNT	1.81e-04	191	122	5	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HIF3A GRIN2C ZIC4 MYO15B KIAA1755	1.81e-04	191	122	5	f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba
ToppCell	ASK454-Epithelial-Secretory\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	MEX3D BCL7C SFMBT2 PM20D2 NPNT	1.81e-04	191	122	5	c63c781e7e93265e591cf494cb4ce8ed797c24fb
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI3 TACC2 HIF3A GPC5 NPNT	1.86e-04	192	122	5	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	TACC2 HMGCS1 DNAH14 NRXN3 NPNT	1.86e-04	192	122	5	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	AT1_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	COL8A1 RTKN2 HEG1 FAM167A NPNT	1.86e-04	192	122	5	0444f9e9cef7403e220e862b5a787443d3f5c9ac
ToppCell	(3)_Chondrocytes-(33)_Chondro-prol/rest\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	COL11A2 HMGCS1 CHADL CCNB1 KIFC1	1.95e-04	194	122	5	c093c5e161b97ad770bfbaad3023eba4537101b5
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL8A1 PRRX1 MAP1A TACC2 NPNT	1.95e-04	194	122	5	aaecde88bd54134a938e76cdf059c1c2653e4e77
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRRX1 ABL1 HIF3A CHRD KIAA1755	2.00e-04	195	122	5	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	AT2_cells-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	TACC2 HMGCS1 PRDX2 ADI1 NPNT	2.00e-04	195	122	5	0792c1e959e933b10ae987d821ff43020dfdabad
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL8A1 MAGI3 RTKN2 GPC5 NPNT	2.00e-04	195	122	5	a71ba5e4043e2d35a45a2c60a96b087e31832345
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A	WHRN PODNL1 SPHK2 SZT2 CDHR2 DELE1 KCNH2 KMT2A TNFAIP2	1.02e-06	195	121	9	3268_UP
Drug	Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; HL60; HG-U133A	SETD1B MAP1A SZT2 BCL7C PIDD1 SCAF4 MIPEP ADI1	1.06e-05	197	121	8	1991_DN
Drug	Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HG-U133A	BCL7C TACC2 DELE1 PRDX2 GRM6 MAP3K6 FAAP100 TM9SF2	1.10e-05	198	121	8	1943_DN
Drug	Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A	SPHK2 SETD1B SZT2 HEG1 PHF3 TNFAIP2 EPS8L3 GP5	1.19e-05	200	121	8	3833_UP
Disease	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE	DDHD1 CYP2U1	1.67e-05	2	121	2	C3539507
Disease	triglyceride measurement, coronary artery disease	SETD1B FBRSL1	9.95e-05	4	121	2	EFO_0001645, EFO_0004530
Disease	bactericidal permeability-increasing protein measurement	EHHADH KIAA1755	1.65e-04	5	121	2	EFO_0020172
Disease	Tinnitus	FBRSL1 RTKN2 CHRD SORCS3 GPC5	2.03e-04	130	121	5	HP_0000360
Disease	urate measurement, bone density	TRPM6 FBRSL1 MAGI3 GRIN2C SFMBT2 DNAH14 MIPEP HELZ2 KIAA1755 GPC5	2.41e-04	619	121	10	EFO_0003923, EFO_0004531
Disease	Combined oxidative phosphorylation deficiency	MARS2 TRIT1 MIPEP	4.72e-04	37	121	3	cv:C4540031
Disease	mitochondrial ubiquitin ligase activator of NFKB 1 measurement	EHHADH KIAA1755	5.89e-04	9	121	2	EFO_0801804
Disease	aortic stenosis, aortic valve calcification	FLNB PRRX1 FBRSL1	6.87e-04	42	121	3	EFO_0000266, EFO_0005239
Disease	Microphthalmos	PRSS56 KMT2D	8.95e-04	11	121	2	C0026010
Disease	coagulation factor XA measurement	WHRN AKNA	8.95e-04	11	121	2	EFO_0020266
Disease	Bipolar I disorder	DAO NRXN3	8.95e-04	11	121	2	C0853193
Disease	pneumonia	TM9SF2 HELZ2 ADI1	9.56e-04	47	121	3	EFO_0003106
Disease	cleft palate (is_implicated_in)	FLNB COL11A2	1.07e-03	12	121	2	DOID:674 (is_implicated_in)
Disease	Spastic Paraplegia, Hereditary	DDHD1 CYP2U1	1.47e-03	14	121	2	C0037773
Disease	Myopia	SCO2 PRSS56	1.69e-03	15	121	2	C0027092
Disease	Disorder of eye	WHRN COL11A2 GRM6 CNNM4 GUCY2D	1.85e-03	212	121	5	C0015397
Disease	myopia (is_implicated_in)	SCO2 SLC39A5	1.93e-03	16	121	2	DOID:11830 (is_implicated_in)
Disease	Dermatitis	NOD2 SHARPIN	1.93e-03	16	121	2	C0011603
Disease	Myeloid Leukemia	PRDX2 KMT2A	2.44e-03	18	121	2	C0023470
Disease	Leukemia, Monocytic, Chronic	PRDX2 KMT2A	2.44e-03	18	121	2	C0023466
Disease	osteochondrodysplasia (is_implicated_in)	FLNB COL11A2	2.72e-03	19	121	2	DOID:2256 (is_implicated_in)
Disease	facial asymmetry measurement	NRXN3 SMAD7	2.72e-03	19	121	2	EFO_0009751
Disease	non-high density lipoprotein cholesterol measurement	PGS1 FBRSL1 AKNA PEX6 MAP3K6 SCAF4 ZIC4 FIZ1 SMAD7	2.73e-03	713	121	9	EFO_0005689
Disease	opioid dependence	DAO TACC2 SFMBT2 ZIC4 NRXN3	2.99e-03	237	121	5	EFO_0005611
Disease	Precursor B-cell lymphoblastic leukemia	ABL1 KMT2A	3.33e-03	21	121	2	C1292769
Disease	renal system measurement, blood urea nitrogen measurement	TFAP2D GNAS	3.65e-03	22	121	2	EFO_0004741, EFO_0004742
Disease	Paroxysmal atrial fibrillation	PRRX1 FBRSL1 KCNH2 SMAD7	3.96e-03	156	121	4	C0235480
Disease	familial atrial fibrillation	PRRX1 FBRSL1 KCNH2 SMAD7	3.96e-03	156	121	4	C3468561
Disease	Persistent atrial fibrillation	PRRX1 FBRSL1 KCNH2 SMAD7	3.96e-03	156	121	4	C2585653

Protein segments in the cluster

Peptide	Gene	Start	Entry
PIRLLRGLLARLPGG	GNAS	476	P84996
PAPLQLGLGRERLGA	FBRSL1	876	Q9HCM7
QRGRAPLGPQDLRLL	CCDC17	316	Q96LX7
VAGGLLRGPPLLLRA	DMRTA2	46	Q96SC8
RLLPGPSLGLAAAGA	TFAP2D	161	Q7Z6R9
IGPNAPLIFERGLRG	HMGCS1	181	Q01581
GLLAVLRAGPGPEAL	RCCD1	81	A6NED2
RGNPELARLRPGLAV	HAGHL	61	Q6PII5
AGALQRDPLLQPGRG	DAO	186	P14920
PHSGRLGPAAIGLLL	DSG3	611	P32926
AEPPRRGSLLELGQG	OTOP3	491	Q7RTS5
GLLARLPRPQDQGCG	FAM201A	121	Q5SY85
PVGSGLRGLQRTLPL	TRIT1	11	Q9H3H1
NLRPGLCLGRIDPKG	MDN1	1561	Q9NU22
PILGAEALPGGLRTL	MAP1A	1111	P78559
LLLLRPGTGLIPDHG	MAGI3	1096	Q5TCQ9
PGGKAARLVLPLGRL	NPNT	461	Q6UXI9
AARLNRDPGLAGGPR	GUCY2D	81	Q02846
LLGAVRGLPDSPRAG	GPC5	41	P78333
LPGGRDRAGRPLLLV	KIAA1755	581	Q5JYT7
VLRRNALGPGLSPEL	LRRC47	81	Q8N1G4
GPTRRLSLPGQLGAL	KCNH2	1131	Q12809
RLDPGLALGPGERER	KIFC1	571	Q9BW19
TLGLLPGARGTQLLP	EHHADH	126	Q08426
LRAQGLGPALLHRPL	MAP3K6	1066	O95382
RPDGAPGALGFLLLL	GPR27	176	Q9NS67
GLAPLEVRVLGPRGL	FLNB	1451	O75369
RLLGLLPGRPGLAAL	PGS1	16	Q32NB8
LPGRPGLAALLGRLS	PGS1	21	Q32NB8
QLLRLLPPRAGAKGG	PTGER1	361	P34995
TRPALQGLLGPGTRL	PEX6	141	Q13608
LEQRPRLGGLQPGQD	EPS8L3	151	Q8TE67
GRLPTPKLRELGGIQ	MDM1	511	Q8TC05
RGLLANLKLGERPPA	NRXN2	176	Q9P2S2
ERPPALLGSQGLRGA	NRXN2	186	Q9P2S2
YLGGLPENRAGLILP	NRXN3	581	Q9Y4C0
AILQQARLALRGPPG	COL11A2	476	P13942
GGLRLELPLSRRGAP	MEX3D	521	Q86XN8
GALSLKPGLPIRGIR	LRBA	31	P50851
PLGPQGLEGLVSRHL	AP5B1	801	Q2VPB7
PLAGAGLELQLERRP	HEG1	46	Q9ULI3
EGLPPSNGILRIQLG	PCDHGC4	741	Q9Y5F7
QLGPGARREVTLPLG	FAAP100	571	Q0VG06
ALQLLGGPFQRRLPG	GAL3ST4	31	Q96RP7
GGARGRPQLTLERPL	MDS2	61	Q8NDY4
RKEGGLGPLNIPLLA	PRDX2	91	P32119
GLRLLKVTQGPGLRP	MYO15B	1351	Q96JP2
SGLPAGALRPLRGLH	PODNL1	326	Q6PEZ8
LRAPLGLLRLDPSGG	CYP2U1	21	Q7Z449
KPGLRPRTALGDIGN	CCNB1	36	P14635
DPDTGLLRNLGPLDR	CDHR2	636	Q9BYE9
ADPELLPGVRLGARL	GRM6	81	O15303
QHEPLGLLRGPAQLG	BSPRY	341	Q5W0U4
PRGGGPLILLDLNDE	BCL7C	81	Q8WUZ0
ALLGGGPRRLLRPDA	LACTBL1	266	A8MY62
GAPELGSLRPGDRAL	FAM83C	566	Q9BQN1
LLPRKERGPPEGGLN	ABL1	571	P00519
RQGRPLPRQGATLAG	AKNA	326	Q7Z591
IPLASLRGEQGPRGE	COL8A1	111	P27658
PSLALAGVGGPDLRR	DNAH14	146	Q0VDD8
PLASDRRLLLGPAGG	FIZ1	286	Q96SL8
LRQHLGLVGGEEPPR	GP5	436	P40197
GLGGAPRQRVPALLL	KMT2A	26	Q03164
ALAERRGPGPVDLLL	DBR1	21	Q9UK59
LALLRGEPGLHLAPG	DDHD1	56	Q8NEL9
LGLGGRRLKSPQAPD	FANCE	171	Q9HB96
LPGPVLSQARGLARL	CHADL	221	Q6NUI6
LGQGRRPGPCRNLAL	HELZ2	271	Q9BYK8
STGLLGARPGLIPLQ	SCAF4	846	O95104
LLLAGAVPPGRGRAA	SCUBE2	26	Q9NQ36
QPQGPGLRTRLLITG	SCO2	51	O43819
LRPAALGLRLPGIGQ	CRLS1	51	Q9UJA2
LRGLQAGARRAPDPG	DPP7	16	Q9UHL4
LLASLGLGRDLQPPG	MAP3K11	651	Q16584
GLLGRALPRTLGPSL	DELE1	6	Q14154
PRRGAGLSLAPLNLG	PIDD1	766	Q9HB75
GLLRNAQELLGPRPG	PRSS56	406	P0CW18
AQELLGPRPGLRRLA	PRSS56	411	P0CW18
RQGLPRIPLRGIFQG	MIB2	146	Q96AX9
SGPPGLQGRLQRLLQ	HCRT	71	O43612
RGGQEPLLPLREAGQ	FAM167A	76	Q96KS9
LRGPALRLAGLPTQQ	RTKN2	6	Q8IZC4
VGALRRGGIPQSPAL	SZT2	1706	Q5T011
QGGLGPIRIPLLSDL	PRDX4	166	Q13162
GRPGAPLVRTGLLLL	SORCS3	11	Q9UPU3
SPDLRRLLGPILDGA	HIF3A	411	Q9Y2N7
PRAAAGLLPGGKARE	STRIP1	36	Q5VSL9
ERPGRFRLELLGAGP	SHARPIN	51	Q9H0F6
LVRPPAGAALGRELL	SETD1B	1536	Q9UPS6
GEGQGPVLFLTRRPL	SWSAP1	31	Q6NVH7
GNDLPLGQPRKLGRE	WHRN	591	Q9P202
DGRRRQLPGLGPAGI	NINL	591	Q9Y2I6
AGLEQPGARELPLLG	NINL	931	Q9Y2I6
DRAGLLPAVLLRPEG	NOXO1	281	Q8NFA2
AALGVRGALEGLPRP	PM20D2	136	Q8IYS1
LLGPRLLRPLLGFLG	SLC39A5	236	Q6ZMH5
HVPLGGLAPLRGLVD	CEP164	141	Q9UPV0
LLLLGSRPARGAGPE	CHRD	16	Q9H2X0
VGGPARGRLLLAAPV	CNNM4	11	Q6P4Q7
TRRLLLLRGPQDGGP	ZXDB	41	P98169
LGLGRRLSLPGPRLD	TTLL11	21	Q8NHH1
LLLPGRLDCRLGPGA	SMAD7	126	O15105
GLPLALLAPLRGAAE	TTLL8	661	A6PVC2
GMGLGSLLPPRQIRL	TNFAIP2	301	Q03169
LAGGRHPPRVQRGAL	TRPM6	1286	Q9BX84
RLGGLGARAAALPPR	MIPEP	6	Q99797
ASQGLGPSLLRGRLP	NOD2	531	Q9HC29
PRLLLLVNPFGGRGL	SPHK2	181	Q9NRA0
NLLEGPLRGKGPIDL	SFMBT2	171	Q5VUG0
PLPGLVGRRNGRAVD	TUG1	6	A0A6I8PU40
GPGLELHRPNLLLGL	PHF3	1331	Q92576
QDALLPARELGGIPR	TACC2	1191	O95359
GRRLGPETGLLFPRL	MARS2	566	Q96GW9
SRPLNGLLRLGLPGD	ZIC4	56	Q8N9L1
LLLLGAVPGPRRSGA	TM9SF2	21	Q99805
KRQPRLLEPGSLGGI	TIMM22	36	Q9Y584
RALERDGGLPGPRLL	TPBGL	216	P0DKB5
VPLLEGLRNGRNPLD	SFMBT1	146	Q9UHJ3
GLRNGRNPLDLIAPG	SFMBT1	151	Q9UHJ3
LQAALPRRGGRLGFP	TOGARAM1	116	Q9Y4F4
RQPALGGRLDSPGNL	PRRX1	11	P54821
RLPFGRLGHEPGLVQ	TTL	46	Q8NG68
LLAQVGPGLGPRARR	ZAR1	86	Q86SH2
LAPEGLRGLAVSGLP	KMT2D	2916	O14686
DPGRPVGLEQLRRLG	ADI1	21	Q9BV57
LELGPGGPRARTQRL	GRIN2C	201	Q14957
LLREPPQQGRALGGL	NECAB2	16	Q7Z6G3